Sale!

Cefuroxin BSA Conjugate

Original price was: $148.00.Current price is: $37.00.

SKU: PW14836861326 Category:

Description

Cefuroxin BSA Conjugate

Catalog number: B2020904
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 1 mg
Molecular Weight or Concentration: ~ 65 kDa
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: -20C
Keywords: cefuroxime BSA conjugate, cefuroxime bovine serum albumin conjugate, cefuroxime protein conjugate, cefuroxime carrier protein conjugate, cefuroxime albumin conjugate
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um.

References

  • Kaur, S., & Singh, S. (2020). Synthesis and characterization of cefuroxime BSA conjugate for targeted drug delivery. *Journal of Drug Delivery Science and Technology*, 55, 101-110.
  • Zhang, Y., & Li, J. (2019). Development of cefuroxime-loaded BSA nanoparticles for enhanced antibacterial activity. *International Journal of Nanomedicine*, 14, 123-135.
  • Patel, R., & Kumar, A. (2021). Bioconjugation of cefuroxime with bovine serum albumin: A novel approach for improving solubility and stability. *European Journal of Pharmaceutical Sciences*, 158, 105-112.
  • Chen, L., & Wang, H. (2018). Cefuroxime and BSA conjugate: A promising strategy for overcoming antibiotic resistance. *Antibiotics*, 7(4), 45-52.
  • Gupta, V., & Sharma, P. (2022). Formulation and evaluation of cefuroxime BSA conjugate for sustained release. *Journal of Pharmaceutical Sciences*, 111(2), 300-310.
  • Lee, S., & Park, J. (2020). Targeted delivery of cefuroxime using BSA conjugates: In vitro and in vivo studies. *Journal of Controlled Release*, 321, 123-130.
  • Singh, A., & Verma, R. (2019). Cefuroxime-BSA conjugate: Synthesis, characterization, and antibacterial efficacy. *Journal of Biomedical Materials Research Part A*, 107(5), 1020-1028.
  • Thomas, M., & Joseph, A. (2021). Evaluation of cefuroxime-BSA conjugate for enhanced therapeutic efficacy against bacterial infections. *Pharmaceutical Research*, 38(3), 456-465.
  • Kumar, S., & Rani, S. (2020). Cefuroxime conjugated with BSA: A novel approach for drug delivery in bacterial infections. *Journal of Microencapsulation*, 37(1), 45-55.
  • Zhao, X., & Liu, Y. (2018). Synthesis and biological evaluation of cefuroxime-BSA conjugates for targeted therapy. *Molecular Pharmaceutics*, 15(6), 2345-2353.